Collection of exhaled breath and exhaled breath condensate in veterinary medicine. A review

Veterinary Quarterly

Volumn 28, Issue 3, 2006, Pages 105-117

  Zollinger, E ^a   Clauss, M ^a   Steinmetz, H W ^a   Hatt, J M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Exhaled breath; Exhaled breath condensate; Hydrogen peroxide; Leukotriene B4; Nitric oxide; Respiratory tract diseases; Review

Indexed keywords

HYDROGEN PEROXIDE; LEUKOTRIENE B4; NITRIC OXIDE;

AIRWAY OBSTRUCTION; BABOON; BREATH ANALYSIS; CAT; CATTLE; CHEMOLUMINESCENCE; ELEPHANT; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPIRED AIR; HORSE; LOWER RESPIRATORY TRACT; MASS SPECTROMETRY; MEDICAL RESEARCH; MINIPIG; NON INVASIVE PROCEDURE; NONHUMAN; ONLINE ANALYSIS; PH MEASUREMENT; RABBIT; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT PARAMETERS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVIEW; RHESUS MONKEY; RODENT; SEAL; SPECIES DIFFERENCE; SPECTROPHOTOMETRY; VETERINARY MEDICINE;

ANIMAL DISEASES; ANIMALS; BREATH TESTS; DIAGNOSIS, DIFFERENTIAL; HYDROGEN PEROXIDE; HYDROGEN-ION CONCENTRATION; LEUKOTRIENE B4; NITRIC OXIDE; RESPIRATORY TRACT DISEASES; SPECIES SPECIFICITY;

ANIMALIA;

EID: 33749468652     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.2006.9695215     Document Type: Review

References (91)

1. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. American Journal of Respiratory and Critical Care Medicine 1999; 160: 2104–2117.
2. American Thoracic Society/European Respiratory Society: Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005. American Journal of Respiratory and Critical Care Medicine 2005; 171: 912–930.
3. Antczak A, Nowak D, Shariati B, Krol M, Piasecka G and Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. European Respiratory Journal 1997; 10: 1235–1241.
4. Babior BM. Phagocytes and oxidative stress. The American Journal of Medicine 2000; 109: 33–44.
5. Bannenberg GL, Giammarresi C and Gustafsson LE. Inhaled carbon dioxide inhibits lower airway nitric oxide formation in the guinea pig. Acta Physiologica Scandinavica 1997; 160: 401–405.
6. Bannenberg GL and Gustafsson LE Stretch-induced stimulation of lower airway nitric oxide formation in the guinea-pig: inhibition by gadolinium chloride. Pharmacology and Toxicology 1997; 81: 13–18.
7. Barnes PJ and Kharitonov SA. Exhaled nitric oxide in monitoring asthma. Drugs of Today 1997; 33: 715–727.
8. Bernareggi M and Cremona G. Measurement of exhaled nitric oxide in humans and animals. Pulmonary Pharmacology and Therapeutics 1999; 12: 331–352.
9. Bernareggi M, Rossoni G, Clini E, Pasini E, Bachetti T, Cremona G, Ambrosino N and Berti F. Detection of nitric oxide in exhaled air of different animal species using a clinical chemiluminescence analyser. Pharmacological Research 1999; 39: 221–224.
10. Biernacki WA, Kharitonov SA and Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003; 58: 294–298.
11. Bigby TD, Lee DM, Meslier N and Gruenert DC. Leukotriene A4 hydrolase activity of human airway epithelial cells. Biochemical and Biophysical Research Communications 1989; 164: 1–7.
12. Borrill Z, Starkey C, Vestbo J and Singh D. Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. European Respiratory Journal 2005; 25: 269–274.
13. Busse WW. Leukotrienes and inflammation. American Journal of Respiratory and Critical Care Medicine 1998; 157: S210–213.
14. Byrnes CA, Dinarevic S, Busst CA, Shinebourne EA and Bush A. Effect of measurement conditions on measured levels of peak exhaled nitric oxide. Thorax 1997; 52: 697–701.
15. Culpitt SV and Russel REK. The measurement of hydrogen peroxide in airways disease. European Respiratory Journal 1999; 68: 246–248.
16. Deaton CM, Marlin DJ, Roberts CA, Smith N, Harris PA and Schroter RC. Monitoring airway inflammation by expired breath condensate. In: The world equine airways symposium and veterinary and comparative respiratory society, 2001. Edinburgh, Schottland, 2001.
17. Deaton CM, Marlin DJ, Smith NC, Smith KC, Newton RJ, Gower SM, Cade SM, Roberts CA, Harris PA, Schroter RC and Kelly FJ. Breath condensate hydrogen peroxide correlates with both airway cytology and epithelial lining fluid ascorbic acid concentration in the horse. Free-Radical Research 2004; 38: 201–208.
18. Dekhuijzen PN, Aben KK, Dekker I, Aarts LP, Wielders PL, van Herwaarden CL and Bast A. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1996; 154: 813–816.
19. Dohlman AW, Black HR and Royall JA. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. American Review of Respiratory Diseases 1993; 148: 955–960.
20. Fey K, Schack S and Sasse HHL. Leukotrien B4 and bradykinin in breath condensate of horses with recurrent airway obstruction. In: The world equine airways symposium and veterinary and comparative respiratory society, 2001. Edinburgh, Schottland, 2001.
21. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME and Smith MJ. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 286: 264–265.
22. Gallati H and Pracht I. [Horseradish peroxidase: kinetic studies and optimization of peroxidase activity determination using the substrates H202 and 3,3,5,5, tetramethylbenzidine]. Journal of Clinical Chemistry and Clinical Biochemistry 1985; 23: 453–460.
23. Gerlach H, Rossaint R, Pappert D, Knorr M and Falke KJ. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet 1994; 343: 518–519.
24. Gustafsson LE. Exhaled nitric oxide as a marker in asthma. European Respiratory Journal Supplementary 1998; 26: 49S-52S.
25. Gustafsson LE, Leone AM, Persson MG, Wiklund NP and Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochemical and Biophysical Research Communications 1991; 181: 852–857.
26. Hanazawa T, Kharitonov SA and Barnes PJ. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. American Journal of Respiratory and Critical Care Medicine 2000; 162: 1273–1276.
27. Henriksen AH, Lingaas-Holmen T, Sue-Chu M and Bjermer L. Combined use of exhaled nitric oxide and airway hyperresponsiveness in characterizing asthma in a large population survey. European Respiratory Journal 2000; 15: 849–855.
28. Hitka P, Vizek M and Wilhelm J. Hypoxia and reoxygenation increase 11202 production in rats. Experimental Lung Research 2003; 29: 585–592.
29. Holma B and Hegg PO. pH- and protein-dependent buffer capacity and viscosity of respiratory mucus. Their interrelationships and influence on health. The Science of the Total Environment 1989; 84: 71–82.
30. Holma B, Lindegren M and Andersen JM. pH effects on ciliomotility and morphology of respiratory mucosa. Archives of Environmental Health 1977; 32: 216–226.
31. Horvath I, Donnelly LE, Kiss A, Kharitonov SA, Lim S. Chung KF and Barnes PJ. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. American Journal of Respiratory and Critical Care Medicine 1998; 158: 1042–1046.
32. Horvath I, Hunt J and Barnes PJ. Exhaled breath condensate: methodological recommendations and unresolved questions. European Respiratory Journal 2005; 26: 523–548.
33. Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J and Crystal RG. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. Journal of Clinical Investigation 1991; 88: 891–897.
34. Hunt JF, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mills TA and Gaston B. Endogenous airway acidification. Implications for asthma pathophysiology. American Journal of Respiratory and Critical Care Medicine 2000; 161: 694–699.
35. Hyslop P and Sklar L. A quantitative fluorimetric assay for the determination of oxidant production by polymorphonuclear leukocytes: its use in the simultaneous fluorimetric assay of cellular activation processes. Analytical Biochemistry 1984; 141: 280–286.
36. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF and Barnes PJ. Neutrophilic inflammation in severe persistent asthma. American Journal of Respiratory and Critical Care Medicine 1999; 160: 1532–1539.
37. Jobsis Q, Raatgeep HC, Hermans PW and de Jongste JC. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. European Respiratory Journal 1997; 10: 519–521.
38. Kharitonov SA. Exhaled nitric oxide and carbon monoxide in asthma. European Respiratory Journal 1999; 9: 212–218.
39. Kharitonov SA and Barnes PJ. Nitric oxide in exhaled air is a new marker of airway inflammation. Monaldi Archives of Chest Disease 1996; 51: 533–537.
40. Kharitonov SA and Barnes PJ. Clinical aspects of exhaled nitric oxide. European Respiratory Journal 2000; 16: 781–792.
41. Kharitonov SA and Barnes PJ. Exhaled markers of inflammation. Current Opinion in Allergy and Clinical Immunology 2001; 1: 217–224.
42. Kharitonov SA, Wells AU, O’Connor BJ, Cole PJ, Hansell DM, Logan-Sinclair RB and Barnes PJ. Elevated levels of exhaled nitric oxide in bronchiectasis. American Journal of Respiratory and Critical Care Medicine 1995; 151: 1889–1893.
43. Kimberly B, Nejadnik B, Giraud GD and Holden WE. Nasal contribution to exhaled nitric oxide at rest and during breathholding in humans. American Journal of Respiratory and Critical Care Medicine 1996; 153: 829–836.
44. Kirschvink N, Marlin D, Delvaux F, Leemans J, Clercx C, Sparkes A and Gustin P. Collection of exhaled breath condensate and analysis of hydrogen peroxide as a potential marker of lower airway inflammation in cats. The Veterinary Journal 2005; 169: 385–396.
45. Kostikas K, Gaga M, Papatheodorou G, Karamanis T, Orphanidou D and Loukides S. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005; 127: 1553–1559.
46. Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P and Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. American Journal of Respiratory and Critical Care Medicine 2002; 165: 1364–1370.
47. Kostikas K, Papatheodorou G, Psathakis K, Panagou P and Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003; 124: 1373–1380.
48. Lewandowski K, Busch T, Lewandowski M, Keske U, Gerlach H and Falke KJ. Evidence of nitric oxide in the exhaled gas of Asian elephants (Elephas maximus). Respiration Physiology 1996; 106: 91–98.
49. Lewandowski K, Busch T, Lohbrunner H, Rensing S, Keske U, Gerlach H and Falke KJ. Low nitric oxide concentrations in exhaled gas and nasal airways of mammals without paranasal sinuses. Journal of Applied Physiology 1998; 85: 405–410.
50. Loukides S, Bouros D, Papatheodorou G, Lachanis S, Panagou P and Siafakas NM. Exhaled H202 in steadystate bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest 2002; 121: 81–87.
51. Loukides S, Bouros D, Papatheodorou G, Panagou P and Siafakas NM. The relationship among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest 2002; 121: 338–346.
52. Loukides S, Horvath I, Wodehouse T, Cole PJ and Barnes PJ. Elevated levels of expired breath hydrogen peroxide in bronchiectasis. American Journal of Respiratory and Critical Care Medicine 1998; 158: 991–994.
53. Luk CK and Dulfano MJ. Effect of pH, viscosity and ionic-strength changes on ciliary beating frequency of human bronchial explants. Clinical Science (London) 1983; 64: 449–451.
54. Lundberg JO, Farkas-Szallasi T, Weitzberg E, Rinder J, Lidholm J, Anggaard A, Hokfelt T, Lundberg JM and Alving K. High nitric oxide production in human paranasal sinuses. Nature Medicine 1995; 1: 370–373.
55. Lundberg JO, Weitzberg E, Nordvall SL, Kuylenstierna R, Lundberg JM and Alving K. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener’s syndrome. European Respiratory Journal 1994; 7: 1501–1504.
56. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA and Barnes PJ. Exhaled nitric oxide in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1998; 157: 998–1002.
57. Mehta S, Lilly CM, Rollenhagen JE, Haley KJ, Asano K and Drazen JM. Acute and chronic effects of allergic airway inflammation on pulmonary nitric oxide production. American Journal of Physiology 1997; 272: L124–131.
58. Mills PC, Marlin DJ, Demoncheaux E, Scott C, Casas I, Smith NC and Higenbottam T. Nitric oxide and exercise in the horse. The Journal of Physiology 1996; 495: 863–874.
59. Montuschi P and Barnes PJ. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacological Sciences 2002; 23: 232–237.
60. Montuschi P and Barnes PJ. Exhaled leukotrienes and prostaglandins in asthma. The Journal of Allergy and Clinical Immunology 2002; 109: 615–620.
61. Montuschi P, Kharitonov SA and Barnes PJ. Exhaled carbon monoxide and nitric oxide in COPD. Chest 2001; 120: 496–501.
62. Montuschi P, Kharitonov SA, Ciabattoni G and Barnes PJ. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003; 58: 585–588.
63. Montuschi P, Ragazzoni E, Valente S, Corbo G, Mondino C, Ciappi G, Barnes P and Ciabattoni G. Validation of leukotriene 134 measurements in exhaled breath condensate. Inflammatory Research 2003; 52: 69–73.
64. Mutlu GM, Garey KW, Robbins RA, Danziger LH and Rubinstein I. Collection and analysis of exhaled breath condensate in humans. American Journal of Respiratory and Critical Care Medicine 2001; 164: 731–737.
65. Nowak D, Kasielski M, Antczak A, Pietras T and Bialasiewicz P. Increased content of thiobarbituric acidreactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respiratory Medicine 1999; 93: 389–396.
66. O’Byrne PM. Why does airway inflammation persist? Is it leukotrienes? American Journal of Respiratory and Critical Care Medicine 2000; 161: S186–187.
67. Ojoo JC, Mulrennan SA, Kastelik JA, Morice AH and Redington AE. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and cystic fibrosis. Thorax 2005; 60: 22–26.
68. Persson MG, Agvald P and Gustafsson LE. Detection of nitric oxide in exhaled air during administration of nitroglycerin in vivo. British Journal of Pharmacology 1994; 111: 825–828.
69. Persson MG and Gustafsson LE. Allergen-induced airway obstruction in guinea-pigs is associated with changes in nitric oxide levels in exhaled air. Acta Physiologica Scandinavica 1993; 149: 461–466.
70. Persson MG, Midtvedt T, Leone AM and Gustafsson LE. Ca2+ dependent and Ca2+ independent exhaled nitric oxide, presence in germ-free animals, and inhibition by arginine analogues. European Journal of Pharmacology 1994; 264: 13–20.
71. Pietra M, Diana A, Forni M, Jochler M and Cinotti S. Evaluation of leukotriene B4 in the canine exhaled breath: standardization of a technique of sample collection. Veterinary Research Communications 2003; 27 Suppl 1: 425–428.
72. Reinhold P, Becher G and Rothe M. Evaluation of the measurement of leukotriene B4 concentrations in exhaled condensate as a noninvasive method for assessing mediators of inflammation in the lungs of calves. American Journal of Veterinary Research 2000; 61: 742–749.
73. Reinhold P, Langenberg A, Becher G and Rothe M. Exhaled condensate- a medium obtained by a non-invasive methode for the detection of inflammation mediators of the lung. Berliner und Miinchner Tierärztliche Wochenschrift 1999; 112: 254–259.
74. Ricciardolo FL, Rado V, Fabbri LM, Sterk PJ, Di Maria GU and Geppetti P. Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide. American Journal of Respiratory and Critical Care Medicine 1999; 159: 557–562.
75. Ruch W, Cooper PH and Baggiolini M. Assay of 11202 production by macrophages and neutrophils with homovanillic acid and horse-radish peroxidase. Journal of Immunological Methods 1983; 63: 347–357.
76. Schedin U, Frostell C and Gustafsson LE. Nitric oxide occurs in high concentrations in monkey upper airways. Acta Physiologica Scandinavica 1995; 155: 473–474.
77. Schleiss MB, Holz O, Behnke M, Richter K, Magnussen H and Jorres RA. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. European Respiratory Journal 2000; 16: 1115–1118.
78. Spada CS, Nieves AL, Krauss AH and Woodward DF. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro. Journal of Leukocyte Biology 1994; 55: 183–191.
79. Sparkes AH, Mardell EJ, Deaton C, Kirschvink N and Marlin D. Exhaled breath condensate (EBC) collection in cats. Description of a non-invasive technique to investigate airway disease. Journal of Feline Medicine and Surgery 2004; 6: 335–338.
80. Stanek KS, Roberts JD, Zapol WM, Falke KJ, Liggins GC and Liggins J. Thoracic circumference and niric oxide activity in the free diving Weddell seal. Antarctic Journal of the United States 1995; 29: 172–174.
81. Stewart TE, Valenza F, Ribeiro SP, Wener AD, Volgyesi G, Mullen JB and Slutsky AS. Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsis. American Journal of Respiratory and Critical Care Medicine 1995; 151: 713–718.
82. Stromberg S, Lonnqvist PA, Persson MG and Gustafsson LE. Lung distension and carbon dioxide affect pulmonary nitric oxide formation in the anaesthetized rabbit. Acta Physiologica Scandinavica 1997; 159: 59–67.
83. Szkudlarek U, Maria L, Kasielski M, Kaucka S and Nowak D. Exhaled hydrogen peroxide correlates with the release of reactive oxygen species by blood phagocytes in Respiratory healthy subjects. Medicine 2003; 97: 718–725.
84. van Beurden WJ, Dekhuijzen PN, Harff GA and Smeenk FW. Variability of exhaled hydrogen peroxide in stable COPD patients and matched healthy controls. Respiration 2002; 69: 211–216.
85. van Beurden WJ, van den Bosch MJ, Janssen WC, Smeenk FW, Dekhuijzen PN and Harff GA. Fluorimetric analysis of hydrogen peroxide with automated measurement. Clinical Laboratory 2003; 49: 637–643.
86. Vaughan J, Ngamtrakulpanit L, Pajewski TN, Turner R, Nguyen TA, Smith A, Urban P, Horn S, Gaston B and Hunt J. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. European Respiratory Journal 2003; 22: 889–894.
87. Weicker S, Karachi TA, Scott JA, McCormack DG and Mehta S. Noninvasive measurement of exhaled nitric oxide in a spontaneously breathing mouse. American Journal of Respiratory and Critical Care Medicine 2001; 163: 1113–1116.
88. Wilhelm J, Frydrychova M and Vizek M. Hydrogen peroxide in the breath of rats: the effects of hypoxia and paraquat. Physiological Research 1999; 48: 445–449.
89. Wilhelm J, Vankova M, Maxova H and Siskova A. Hydrogen peroxide production by alveolar macrophages is increased and its concentration is elevated in the breath of rats exposed to hypoxia: relationship to lung lipid peroxidation. Physiological Research 2003; 52: 327–332.
90. Wyse CA, Hammond J, Arteaga A, Cumming D, Cooper JM, McEwan JD and Yam PS. Collection and analysis of exhaled breath condensate hydrogen peroxide in conscious healthy dogs. The Veterinary Record 2004; 155: 744–746.
91. Wyse CA, Preston T, Yarn PS, Sutton DG, Christley RM, Hotchkiss JW, Mills CA, Glidle A, Cumming DR, Cooper JM and Love S. Current and future uses of breath analysis as a diagnostic tool. Veterinary Record 2004; 154: 353–360.